ABCELLERA BIOLOGICS (8QQ) — Capital Reinvestment Ratio
ABCELLERA BIOLOGICS (8QQ) has a Capital Reinvestment Ratio of 0.26x as of December 2022, meaning it reinvests 0% of its operating cash flow (€277.36 Million) in capital expenditures (€72.66 Million). See ABCELLERA BIOLOGICS balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
ABCELLERA BIOLOGICS Capital Reinvestment Ratio (2021–2022)
This chart tracks ABCELLERA BIOLOGICS's Capital Reinvestment Ratio across 2 annual periods. Check ABCELLERA BIOLOGICS (8QQ) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for ABCELLERA BIOLOGICS (2021–2022)
Year-by-year Capital Reinvestment Ratio for ABCELLERA BIOLOGICS from 2021 to 2022. For live market cap and broader valuation context, see 8QQ stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.26x | €277.36 Million | €72.66 Million | ▲ +9.6% |
| 2021 | 0.24x | €244.58 Million | €58.45 Million | — |